Aktuelle Seite: Startseite » Stellenangebote » PhD student in Bioin­for­matics for Rare Disease Research

PhD student in Bioin­for­matics for Rare Disease Research

Are you passionate about the appli­cation of bioin­for­matics to genome-based medicine? The Chair of Compu­ta­tional Molecular Medicine at the Technical University of Munich (TUM) is seeking a talented and driven individual to join our dynamic team. As part of the newly funded European project ERDERA, you will develop innovative bioin­for­matics methods to improve and accelerate diagno­stics and identi­fi­cation of treatment options for rare diseases.

About us
The Chair of Compu­ta­tional Molecular Medicine, led by Prof Julien Gagneur, develops compu­ta­tional approaches to study genomes. Appli­ca­tions of our work range from under­standing basic mecha­nisms governing gene expression to unravelling genetic aberra­tions triggering rare diseases and cancer. More at https://www.cs.cit.tum.de/cmm/home/.

The project
ERDERA, the European Rare Disease Research Alliance (https://www.ejprarediseases.org/erdera/) is a new 7‑year EC-funded project starting 1st September 2024. ERDERA aims to improve the diagnosis and treatment of rare diseases in Europe. It integrates under one roof research capacity, resources, and service from 171 public insti­tu­tions, hospitals, and companies spanning patient recruit­ments, genome sequencing and omics profiling, data integration, software develo­pment for diagnosis and treatment recom­men­da­tions, and the develo­pment of new thera­peutics. ERDERA colla­bo­rates with national initia­tives such as Germany’s genomic medicine project (https://www.bundesgesundheitsministerium.de/en/en/international/european-health-policy/genomde-en.html) that will yield 10,000s of genomes from routine diagno­stics for research. Our team co-leads the ERDERA work package on “Diagnostic Research Workstream — Genomic innovation to shorten time to diagnosis”.

Your role
You will develop and apply methods that jointly process DNA variants and results derived from RNA-seq data to increase analysis speed and relia­bility. This will include improving and integrating non-coding variant annotation tools and aberrant event callers, for which our lab has made substantial contri­bu­tions (e.g. AbSplice, AbExp, OUTRIDER, FRASER). You will integrate data from multiple centers, develop and implement workflows covering quality control proce­dures, compre­hensive analysis, and automa­ti­cally generated reports. Moreover, you will develop guide­lines for results inter­pre­tation and follow-up on their imple­men­tation and outcome.

More infor­mation:
https://drive.google.com/file/d/1wQirTZABk6liyd-MIoZb_wMrAbkro0Pz/view